{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:06:45Z","timestamp":1774555605293,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["278901"],"award-info":[{"award-number":["278901"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2010T084"],"award-info":[{"award-number":["2010T084"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["200500003"],"award-info":[{"award-number":["200500003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijcrp.2024.200358","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T08:25:42Z","timestamp":1733905542000},"page":"200358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of antihypertensives with and without IL-6 lowering properties on long-term blood pressure control: The prospective HELIUS cohort"],"prefix":"10.1016","volume":"24","author":[{"given":"Hillmann","family":"Batuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrike","family":"Galenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Moll van Charante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert-Jan van der","family":"Born","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-001X","authenticated-orcid":false,"given":"Felix P.","family":"Chilunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10304","key":"10.1016\/j.ijcrp.2024.200358_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ijcrp.2024.200358_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ncpneph0283","article-title":"Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension","volume":"2","author":"Vaziri","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"6","key":"10.1016\/j.ijcrp.2024.200358_bib3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/jcp.31019","article-title":"Inflammation and hypertension: underlying mechanisms and emerging understandings","volume":"238","author":"Aboukhater","year":"2023","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200358_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CRD.0000000000000428","article-title":"Anti-inflammatory therapeutics and coronary artery disease","volume":"31","author":"Eghtedari","year":"2023","journal-title":"Cardiol. Rev."},{"issue":"14","key":"10.1016\/j.ijcrp.2024.200358_bib5","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.3390\/ijms20143458","article-title":"Effect of different classes of antihypertensive drugs on endothelial function and inflammation","volume":"20","author":"Silva","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcrp.2024.200358_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijcrp.2024.200358_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ijcrp.2024.200358_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101012","article-title":"Inflammation and its associations with aortic stiffness, coronary artery disease and peripheral artery disease in different ethnic groups: the HELIUS Study","volume":"38","author":"Hayfron-Benjamin","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijcrp.2024.200358_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-13-402","article-title":"Unravelling the impact of ethnicity on health in Europe: the HELIUS study","volume":"13","author":"Stronks","year":"2013","journal-title":"BMC Publ. Health"},{"issue":"3","key":"10.1016\/j.ijcrp.2024.200358_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/13557850802509206","article-title":"The utility of \u2018country of birth\u2019for the classification of ethnic groups in health research: the Dutch experience","volume":"14","author":"Stronks","year":"2009","journal-title":"Ethn. Health"},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200358_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochemical journal"},{"key":"10.1016\/j.ijcrp.2024.200358_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-016-0042-0","article-title":"A review on prescribing patterns of antihypertensive drugs","volume":"22","author":"Jarari","year":"2015","journal-title":"Clinical hypertension"},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200358_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0002-8703(88)90557-1","article-title":"Transition from high cardiac output to elevated vascular resistance in hypertension","volume":"116","author":"Julius","year":"1988","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcrp.2024.200358_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cjca.2020.02.003","article-title":"How structure, mechanics, and function of the vasculature contribute to blood pressure elevation in hypertension","volume":"36","author":"Schiffrin","year":"2020","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200358_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00041552-200303000-00009","article-title":"Vascular inflammation: a role in vascular disease in hypertension?","volume":"12","author":"Virdis","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.ijcrp.2024.200358_bib16","article-title":"Amlodipine and landmark trials: a review","volume":"5","author":"Khan","year":"2021","journal-title":"Journal of Cardiology and Cardiovascular Sciences"},{"key":"10.1016\/j.ijcrp.2024.200358_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003495-200161070-00007","article-title":"Barnidipine","volume":"61","author":"Malhotra","year":"2001","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200358_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.fjc.0000211743.93701.eb","article-title":"Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension","volume":"47","author":"Derosa","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200358_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0735-1097(97)00145-9","article-title":"Role of cytokines in the mechanism of action of amlodipine: the PRAISE heart failure trial","volume":"30","author":"Mohler","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4_pt_2","key":"10.1016\/j.ijcrp.2024.200358_bib20","doi-asserted-by":"crossref","first-page":"II18","DOI":"10.1161\/01.HYP.5.4_Pt_2.II18","article-title":"Pharmacokinetics and metabolism of nifedipine","volume":"5","author":"Raemsch","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcrp.2024.200358_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03256583","article-title":"Clevidipine: a review of its use in the management of acute hypertension","volume":"9","author":"Deeks","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.ijcrp.2024.200358_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200565002-00002","article-title":"Vascular effects of calcium channel antagonists: new evidence","volume":"65","author":"Richard","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ijcrp.2024.200358_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003495-197815030-00001","article-title":"Verapamil: a review of its pharmacological properties and therapeutic use","volume":"15","author":"Singh","year":"1978","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.ijcrp.2024.200358_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0002-9149(89)90076-3","article-title":"Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter","volume":"63","author":"Salerno","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200358_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2165\/00003495-199549030-00008","article-title":"Ramipril: an updated review of its therapeutic use in essential hypertension and heart failure","volume":"49","author":"Frampton","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ijcrp.2024.200358_bib26","first-page":"12","article-title":"Pharmacological and pharmaceutical profile of valsartan: a review","author":"Siddiqui","year":"2011","journal-title":"J. Appl. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200358_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-199426010-00002","article-title":"Clinical pharmacokinetics of ramipril","volume":"26","author":"Meisel","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijcrp.2024.200358_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/DDDT.S76942","article-title":"A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects","author":"Jung","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"7","key":"10.1016\/j.ijcrp.2024.200358_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/1389200217666160524143843","article-title":"Drug interactions with angiotensin receptor blockers: role of human cytochromes P450","volume":"17","author":"Yang","year":"2016","journal-title":"Curr. Drug Metabol."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487524001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487524001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:10:07Z","timestamp":1742487007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487524001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":29,"alternative-id":["S2772487524001235"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200358","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of antihypertensives with and without IL-6 lowering properties on long-term blood pressure control: The prospective HELIUS cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200358"}}